Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific t lymphocyte responses in foreskin in rhesus monkeys

Journal of Virology

Volumn 88, Issue 7, 2014, Pages 3756-3765

  Balandya, Emmanuel ^a   Miller, Andrew D ^a   Beck, Matthew ^a   Liu, Jinyan ^a   Li, Hualin ^a   Borducchi, Erica ^a   Smith, Kaitlin ^a   Cabral, Crystal ^a   Stanley, Kelly ^a   Maxfield, Lori F ^a   Barouch, Dan H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ADENOVIRUS SEROTYPE 26; ADENOVIRUS SEROTYPE 35; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; IMMUNE RESPONSE; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREPUCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS INDUCTION;

ADENOVIRIDAE; ANIMALS; DRUG CARRIERS; FORESKIN; GENETIC VECTORS; IMMUNOPHENOTYPING; INJECTIONS, INTRAMUSCULAR; MACACA MULATTA; MALE; SAIDS VACCINES; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; TIME FACTORS;

EID: 84895437772     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03771-13     Document Type: Article

References (30)

1. Dinh MH, Fahrbach KM, Hope TJ. 2011. The role of the foreskin in male circumcision: an evidence-based review. Am. J. Reprod. Immunol. 65: 279-283. http://dx.doi.org/10.1111/j.1600-0897.2010.00934.x.
2. Fahrbach KM, Barry SM, Anderson MR, Hope TJ. 2010. Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission. Mucosal Immunol. 3:410-418. http://dx.doi.org/10.1038/mi.2010.18.
3. Fischetti L, Barry SM, Hope TJ, Shattock RJ. 2009. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 23:319-328. http://dx.doi.org/10.1097/QAD.0b013e328321b778.
4. Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu MC, Gibault L, Thiounn N, Tomasini J, Wolf JP, Bomsel M. 2010. Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol. 3:506-522. http://dx.doi.org/10.1038/mi.2010.32.
5. McCoombe SG, Short RV. 2006. Potential HIV-1 target cells in the human penis. AIDS 20:1491-1495. http://dx.doi.org/10.1097/01.aids .0000237364.11123.98.
6. Morris BJ, Wamai RG. 2012. Biological basis for the protective effect conferred by male circumcision against HIV infection. Int. J. STD AIDS 23:153-159. http://dx.doi.org/10.1258/ijsa.2011.011228.
7. Qureshi H, Ma ZM, Huang Y, Hodge G, Thomas MA, DiPasquale J, DeSilva V, Fritts L, Bett AJ, Casimiro DR, Shiver JW, Robert-Guroff M, Robertson MN, McChesney MB, Gilbert PB, Miller CJ. 2012. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. J. Virol. 86:2239-2250. http://dx.doi.org/10 .1128/JVI.06175-11.
8. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. 2005. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2:e298. http://dx.doi.org/10.1371/journal.pmed.0020298.
9. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO. 2007. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369:643-656. http://dx.doi.org/10.1016/S0140-6736 (07)60312-2.
10. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ. 2007. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369:657-666. http://dx.doi.org/10.1016/S0140-6736(07)60313-4.
11. Rothaeusler K, Ma ZM, Qureshi H, Carroll TD, Rourke T, McChesney MB, Miller CJ. 2012. Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques. J. Virol. 86:7098-7106. http://dx.doi.org/10.1128/JVI.00410-12.
12. Prodger JL, Gray R, Kigozi G, Nalugoda F, Galiwango R, Hirbod T, Wawer M, Hofer SO, Sewankambo N, Serwadda D, Kaul R. 2012. Foreskin T-cell subsets differ substantially from blood with respect to HIV coreceptor expression, inflammatory profile, and memory status. Mucosal Immunol. 5:121-128. http://dx.doi.org/10.1038/mi.2011.56.
13. Li H, Liu J, Carville A, Mansfield KG, Lynch D, Barouch DH. 2011. Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys. J. Virol. 85:11007-11015. http://dx.doi.org/10.1128/JVI .05346-11.
14. Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, Stablein D, Pau MG, Schuitemaker H, Sadoff JC, Billings EA, Rao M, Robb ML, Kim JH, Marovich MA, Goudsmit J, Michael NL. 2012. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 482:89-93. http://dx.doi.org/10.1038/nature10766.
15. + T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. J. Virol. 84:9810-9816. http://dx.doi.org/10.1128/JVI.01157-10.
16. Li H, Rhee EG, Masek-Hammerman K, Teigler JE, Abbink P, Barouch DH. 2012. Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys. J. Virol. 86:10862-10865. http://dx.doi.org/10 .1128/JVI.00928-12.
17. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC, Axthelm MK, Picker LJ. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168:29-43.
18. Picker LJ, Reed-Inderbitzin EF, Hagen SI, Edgar JB, Hansen SG, Legasse A, Planer S, Piatak M, Jr, Lifson JD, Maino VC, Axthelm MK, Villinger F. 2006. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J. Clin. Invest. 116:1514-1524. http://dx.doi.org/10.1172/JCI27564.
19. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361: 2209-2220. http://dx.doi.org/10.1056/NEJMoa0908492.
20. Derrick SC, Yabe IM, Yang A, Morris SL. 2011. Vaccine-induced antituberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. Vaccine 29:2902-2909. http: //dx.doi.org/10.1016/j.vaccine.2011.02.010.
21. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712. http://dx.doi.org/10.1038/44385.
22. Liu CM, Hungate BA, Tobian AA, Serwadda D, Ravel J, Lester R, Kigozi G, Aziz M, Galiwango RM, Nalugoda F, Contente-Cuomo TL, Wawer MJ, Keim P, Gray RH, Price LB. 2013. Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria. mBio 4:e00076-13. http://dx.doi.org/10.1128/mBio.00076-13.
23. + T cell stimulatory capacity. J. Leukoc. Biol. 83:1118-1127. http://dx.doi.org/10.1189/jlb.0807567.
24. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. 1991. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 88:4220-4224. http://dx.doi.org/10.1073/pnas.88.10 .4220.
25. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893. http://dx.doi.org/10.1016/S0140-6736(08) 61591-3.
26. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372:1894-1905. http://dx.doi.org/10.1016 /S0140-6736(08)61592-5.
27. + T-cell activation via CD46 ligation. Proc. Natl. Acad. Sci. U. S. A. 108:7499-7504. http://dx.doi.org/10.1073/pnas.1017146108.
28. Havenga MJ, Lemckert AA, Ophorst OJ, van Meijer M, Germeraad WT, Grimbergen J, van Den Doel MA, Vogels R, van Deutekom J, Janson AA, de Bruijn JD, Uytdehaag F, Quax PH, Logtenberg T, Mehtali M, Bout A. 2002. Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J. Virol. 76:4612-4620. http://dx.doi .org/10.1128/JVI.76.9.4612-4620.2002.
29. Liu J, Ewald BA, Lynch DM, Denholtz M, Abbink P, Lemckert AA, Carville A, Mansfield KG, Havenga MJ, Goudsmit J, Barouch DH. 2008. Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J. Virol. 82:4844-4852. http://dx.doi.org/10.1128/JVI .02616-07.
30. Teigler JE, Iampietro MJ, Barouch DH. 2012. Vaccination with adenovirus serotypes 35, 26, and 48 elicits greater innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. J. Virol. 86:9590-9598. http: //dx.doi.org/10.1128/JVI.00740-12.